[80], calculated a cumulative cfDNA methylation score (CMS) based on Short stature homeobox 2 (SHOX2) and septin 9 (SEPT9) methylation status in blood samples of 115 cancer patients, including 9 with sarcoma. This evidence concerns the gene SHOX2 and sarcoma.